EasySep™小鼠TIL（CD45）正选试剂盒
关于我们
-
STEMCELL Technologies Partners with the ATS to Offer Travel Scholarships STEMCELL Technologies has entered into a partnership with the American Thoracic Society (ATS) to offer the STEMCELL Technologies Scholarships to attend the ATS 2018 International Conference in San Diego, California -
STEMCELL Technologies Signs Exclusive License with IU Innovation and Commercialization Office for Inner Ear Organoid Technology STEMCELL Technologies has signed an exclusive license with Indiana University Innovation and Commercialization Office for patented rights to groundbreaking inner ear organoid technologies -
STEMCELL Technologies Brings Groundbreaking Intestinal and Brain Organoid Culture Tools to the Global Research Community STEMCELL Technologies Inc. has released two product lines for organoid research that will enable scientists to create powerful models for studying human disease in the lab -
STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX™, an Innovation Empowering Epithelial Cell Biology and Cell Therapy STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation -
How the Global Talent Stream Can Improve Vancouver’s Biotechnology Sector With Canada's fast-growing tech sector facing a shortage of 220,000 workers by 2020, the federal government is right to expedite the immigration process for highly skilled workers with its new Global Talent Stream -
Three Finalists Announced for the Inaugural Bloom Burton Award Annual award to recognize the most significant contributor to Canada's healthcare industry -
Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies STEMCELL and CDI will work together on progressive solutions for the life science tools market -
STEMCELL Technologies to Launch CloneR™ to Facilitate Genome Editing of Human Pluripotent Stem Cells STEMCELL Technologies announces the development of CloneR™, a novel medium formulation to aid researchers in their ability to successfully genome edit human pluripotent stem cells -
Dr. Allen Eaves of STEMCELL Technologies Inc. named EY Entrepreneur Of The Year™ Pacific 2016 Dr. Allen Eaves, Chairman, President and Chief Executive Officer of STEMCELL Technologies, a global biotechnology company that supplies tools and services to enable life science research, is this year's Entrepreneur Of The Year Pacific winner -
STEMCELL Technologies Opens New Office and Laboratories in Cambridge, UK STEMCELL Technologies UK has recently celebrated the grand opening of their Cambridge-based facility -
STEMCELL Technologies Signs Exclusive License Agreement with Cincinnati Children’s for Stem Cell-Derived Organoid Technology This agreement grants STEMCELL a license to novel methods for generating organoid models and to develop cell culture media and tools that would enable scientists to create organoids from PSCs in their own laboratories -
GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies’ T-Cell reagents Exclusive licensing agreement will provide cGMP grade reagents to further enable development and manufacturing of cellular immunotherapies
